Jill Langley
Pediatrics · Sylva, NCNPI 1194161414
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $939, 5.7 times the $165 reported in 2021. Among pediatrics clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$278
- AbbVie$190
- Lilly USA, LLC$184
- Johnson & Johnson$167
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$156
- Corium, LLC$138
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,156100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $278 |
| AbbVie | 14 | $190 |
| Lilly USA, LLC | 9 | $184 |
| Johnson & Johnson | 9 | $167 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $156 |
| Corium, LLC | 8 | $138 |
| Bayer | 8 | $135 |
| Abbott | 4 | $104 |
| Pfizer | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| AstraZeneca | 4 | $74 |
| Exact Sciences | 5 | $73 |
| Corcept Therapeutics | 5 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $62 |
| Merck | 3 | $54 |
| Amgen | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| GSK | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $20 |
| Organogenesis Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,156 in reported general payments places this provider in the 90th percentile of 1,818 pediatrics providers in North Carolina.
Other pediatrics in Sylva
- Dwight KoeberlDurham$8.4M
- Priya KishnaniDurham$5.8M
- James AndersonHigh Point$669K
- Joseph MuenzerChapel Hill$237K
- Ifeyinwa OsunkwoCharlotte$218K
- Edward SmithDurham$164K
- Katherine SmithRaleigh$133K
- James StillRaleigh$105K
- Richard BrugmanGastonia$73K
- Daniel LandiDurham$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.